Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography

Heart

Volumn 91, Issue 6, 2005, Pages 737-742

  Biagini, E ^a,c   Schinkel, A F L ^a   Bax, J J ^b   Rizzello, V ^a   Van Domburg, R T ^a   Krenning, B J ^a   Bountioukos, M ^a   Pedone, C ^a   Vourvouri, E C ^a   Rapezzi, C ^c   Branzi, A ^c   Roelandt, J R T C ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART DEATH; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SILENT MYOCARDIAL INFARCTION; ST SEGMENT DEPRESSION; STRESS ECHOCARDIOGRAPHY;

ANGINA PECTORIS; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 20044377486     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.041087     Document Type: Article

References (39)

1. Laukkanen JA, Kurl S, Lakka TA, et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 2001;38:72-9.
2. Almeda FQ, Kason TT, Nathan S, et al. Silent myocardial ischemia: concepts and controversies. Am J Med 2004;116:112-8.
3. Miranda CP, Lehmann KG, Lachterman B, et al. Comparison of silent and symptomatic ischemia during exercise testing in men. Ann Intern Med 1991;114:649-56.
4. Bolognese L, Rossi L, Sarasso G, et al. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. J Am Coll Cardiol 1992;19:953-9.
5. Mahmarian JJ, Pratt CM, Cocanougher MK, et al. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography. Circulation 1990;82:1305-15.
6. Hecht HS, DeBord L, Sotomayor N, et al. Truly silent ischemia and the relationship of chest pain and ST segment changes to the amount of ischemic myocardium: evaluation by supine bicycle stress echocardiography. J Am Coll Cardiol 1994;23:369-76.
7. Gasperetti CM, Burwell LR, Beller GA. Prevalence of and variables associated with silent myocardial ischemia on exercise thallium-201 stress testing. J Am Coll Cardiol 1990;16:115-23.
8. Hecht HS, Shaw RE, Bruce T, et al. Silent ischemia: evaluation by exercise and redistribution tomographic thallium-201 myocardial imaging. J Am Coll Cardiol 1989;14:895-900.
9. Warwick TH, Nemec JJ, Torelli J, et al. Extent and severity of abnormal left ventricular wall motion detected by exercise echocardiography during painful and silent ischemia. Am J Cardiol 1992;69:1483-4.
10. Mark DB, Hlatky MA, Califf RM, et al. Painless exercise ST deviation on the treadmill: long-term prognosis. J Am Coll Cardiol 1989;14:885-92.
11. Marwick TH, Case C, Short L, et al. Prediction of mortality in patients without angina: use of an exercise score and exercise echocardiography. Eur Heart J 2003;24:1223-30.
12. Nihoyannopoulos P, Marsonis A, Joshi J, et al. Magnitude of myocardial dysfunction is greater in painful than in painless myocardial ischemia: an exercise echocardiographic study. J Am Coll Cardiol 1995;25:1507-12.
13. Narins CR, Zareba W, Moss AJ, et al. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol 1997;29:756-63.
14. Klein J, Chao SY, Berman DS, et al. Is 'silent' myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation 1994;89:1958-66.
15. Travin MI, Flores AR, Boucher CA, et al. Silent versus symptomatic ischemia during a thallium-201 exercise test. Am J Cardiol 1991;68:1600-8.
16. Marcassa C, Galli M, Baroffio C, et al. Ischemic burden in silent and painful myocardial ischemia: a quantitative exercise sestamibi tomographic study. J Am Coll Cardiol 1997;29:948-54.
17. Segar DS, Brown SE, Sawada SG, et al. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992;19:1197-202.
18. Lancellotti P, Benoit T, Rigo P, et al. Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction. Heart 2001;86:510-5.
19. Schinkel AF, Bax JJ, Geleijnse ML, et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003;24:789-800.
20. Sicari R, Pasanisi E, Venneri L, et al. Stress echo results predict mortality: a large-scale multicenter prospective international study. J Am Coll Cardiol 2003;41:589-95.
21. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
22. Elhendy A, van Domburg RT, Bax JJ, et al. The grade of worsening of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalities. Heart 2000;83:35-9.
23. Hoffmann R, Marwick TH, Poldermans D, et al. Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J 2002;23:821-9.
24. Marwick TH, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography, scintigraphy or both? J Am Coll Cardiol 1993;22:159-67.
25. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-202.
26. Egstrup K. Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia. Am Heart J 1988;116:971-8.
27. Stone PH, Gibson RS, Glasser SP, et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina: differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS study group. Circulation 1990;82:1962-72.
28. Quyyumi AA, Crake T, Wright CM, et al. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate. Br Heart J 1987;57:505-11.
29. Davies RF, Habibi H, Klinke WP, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian amlodipine/atenolol in silent ischemia study (CASIS) investigators. J Am Coll Cardiol 1995;25:619-25.
30. Resnekov L. Silent myocardial ischemia: therapeutic implications. Am J Med 1985;79:30-4.
31. Aengevaeren WR, Uijen GJ, Jukema JW, et al. Functional evaluation of lipid-lowering therapy by pravastatin in the regression growth evaluation statin study (REGRESS). Circulation 1997;96:429-35.
32. Knatterud GL, Bourassa MG, Pepine CJ, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the asymptomatic cardiac ischemia pilot (ACIP) study. J Am Coll Cardiol 1994;24:11-20.
33. Bonou M, Benroubis A, Kranidis A, et al. Functional and prognostic significance of silent ischemia during dobutamine stress ecnocardiography in the elderly. Coron Artery Dis 2001;12:499-506.
34. Elhendy A, Schinkel AFL, van Domburg RT, et al. Comparison of late outcome in patients with versus without angina pectoris having reversible perfusion abnormalities during dobutamine stress technetium-99m sestamibi single-photon emission computed tomography. Am J Cardiol 2003;91:264-8.
35. Bigi R, Galati A, Curti G, et al. Different clinical and prognostic significance of painful and silent myocardial ischemia detected by exercise electrocardiography and DSE after uncomplicated myocardial infarction. Am J Cardiol 1998;81:75-8.
36. Mazzone A, Cusa C, Mazzucchelli I, et al. Increased production of inflammatory cytokines in patients with silent myocardial ischemia. J Am Coll Cardiol 2001;38:1895-901.
37. Rosen SD, Paulesu E, Nihoyannopaulos P, et al. Silent ischemia as a central problem: regional brain activation compared in silent and painful myocardial ischemia. Ann Intern Med 1996;124:939-49.
38. Deedwania PC, Carbajal EV. Silent myocardial ischemia: a clinical perspective. Arch Intern Med 1991;151:2373-82.
39. Weiner DA, Ryan TJ, McCabe CH, et al. Comparison of coronary artery bypass surgery and medical therapy in patients with exercised-induced silent myocardial ischemia: a report from the coronary artery surgery study (CASS) registry. J Am Coll Cardiol 1988;12:595-9.